Selank

Description

Selank is a synthetic peptide derived from tuftsin, recognized for its anxiolytic and cognitive-enhancing properties. It is extensively researched for its influence on mental well-being and cognitive function.

Overview

Selank, a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, was developed in Russia in the early 1990s. It is primarily investigated for its anxiolytic and nootropic effects, showing promise in ameliorating anxiety and enhancing cognitive performance. While approved in Russia and some CIS countries for generalized anxiety disorder, Selank remains a research compound in the United States and lacks FDA approval for clinical use. Its multifaceted actions suggest potential applications beyond anxiety and cognition, including immunomodulation and neuroprotection. Research indicates Selank's ability to reduce anxiety without the sedative side effects often associated with conventional anxiolytics. Studies have demonstrated its capacity to positively influence mood, improve stress adaptation, and offer protection against alcohol-induced memory impairment. This peptide also plays a role in regulating the immune system, showing activity in modulating cytokine responses and exhibiting antiviral properties. Furthermore, Selank has been explored for its cognitive-enhancing capabilities. It appears to improve learning, memory consolidation, and attention, particularly in models of cognitive impairment. Its effects on serotonin metabolism and its ability to enhance GABAergic neurotransmission are thought to underpin these cognitive benefits, presenting it as a potential therapeutic agent for various neurological and psychological conditions.

Mechanism of Action

Selank primarily acts on the central nervous system by modulating the activity of neurotransmitters such as GABA, serotonin, and dopamine. It alters the expression of GABA receptor genes, increasing their affinity for GABA, which helps reduce neuronal excitability. Additionally, Selank protects endogenous enkephalins from degradation, contributing to its anxiety-reducing and pain-modulating effects.

Benefits

• •Reduces anxiety and promotes calmness
• •Enhances learning and memory recall
• •Improves stress resilience and adaptation
• •Supports balanced immune function
• •Potentially offers neuroprotection

Dosing Notes

Intranasal administration is the preferred method for Selank due to its ability to bypass the blood-brain barrier for rapid central nervous system effects. A common daily dosage in research settings ranges from 750 mcg to 1 mg, typically divided into two or three administrations throughout the day. Subcutaneous injections are another option, usually dosed at 150-300 mcg daily, which may result in a slower onset but potentially longer-lasting effects. While specific guidelines on study duration are limited, observable outcomes are often noted after at least two weeks of consistent dosing. Some researchers suggest a week-long break after every one to two weeks of administration, although cycling is not conclusively established as necessary.

Reported Side Effects

• •Headaches
• •Nausea
• •Injection site pain/redness
• •Sinus irritation (nasal administration)
• •Sore throat

Safety Notes

Limited human safety data exists for Selank, and it is not FDA-approved for clinical use in the United States. While studies generally report a favorable safety profile with minimal side effects, the majority of research has been conducted by a single institution (Russian Academy of Sciences) and often over short durations. Researchers should exercise caution and conduct thorough due diligence. Common anecdotal side effects reported include headaches, nausea, injection site reactions (for subcutaneous administration), and sinus irritation (for intranasal administration).

Scientific References